Masking for COVID-19 Is Associated with Decreased Emergency Department Utilization for Non-COVID Viral Illnesses and Respiratory Conditions in Maryland - 28/09/21
Abstract |
Background |
Masking, which is known to decrease the transmission of respiratory viruses, was not widely practiced in the United States until the coronavirus disease 2019 (COVID-19) pandemic. This provides a natural experiment to determine whether the percentage of community masking was associated with decreases in emergency department (ED) visits due to non-COVID viral illnesses (NCVIs) and related respiratory conditions.
Methods |
In this observational study of ED encounters in a 11-hospital system in Maryland during 2019-2020, year-on-year ratios for all complaints were calculated to account for “lockdowns” and the global drop in ED visits due to the pandemic. Encounters for specific complaints were identified using the International Classification of Diseases, version 10. Encounters with a positive COVID test were excluded. Linear regression was used to determine the association of publicly available masking data with ED visits for NCVI and exacerbations of asthma and chronic obstructive pulmonary disease (COPD), after adjusting for patient age, sex, and medical history.
Results |
There were 285,967 and 252,598 ED visits across the hospital system in 2019 and 2020, respectively. There was a trend toward an association between the year-on-year ratio for all ED visits and the Maryland stay-at-home order (parameter estimate = -0.0804, P = .10). A 10% percent increase in the prevalence of community masking was associated with a 17.0%, 8.8%, and 9.4% decrease in ED visits for NCVI and exacerbations of asthma exacerbations and chronic obstructive pulmonary disease, respectively (P < .001 for all).
Conclusions |
Increasing the prevalence of masking is associated with a decrease in ED visits for viral illnesses and exacerbations of asthma and COPD. These findings may be valuable for future public health responses, particularly in future pandemics with respiratory transmission or in severe influenza seasons.
Le texte complet de cet article est disponible en PDF.Keywords : COVID, Emergency medicine, Epidemiology, Public health
Plan
Funding: ZDWD, KSZ, the data extraction, and data analysis, were all supported through grants from National Foundation of Emergency Medicine. The National Foundation of Emergency Medicine was not involved in the development of the analysis or the contents of the report. |
|
Conflicts of Interest: ZDWD reports serving on an advisory board for Perdue Pharmaceuticals to assist with the development medications to be used against the opioid epidemic. CBC reports serving as a consultant to bioMerieux on biomarkers; as the President of the Board of Directors of the National Foundation of Emergency Medicine (NFEM), a non-profit organization dedicated to the development of emergency medicine research, innovation and investigators; and receives funding for COVID-19 research from the National Institutes of Health (NIAID, NHLBI) and the Bill & Melinda Gates Foundation. BS, RMC, DM, LP, MS-K report none. |
|
Authorship: All authors had access to the data and a role in writing this manuscript. |
Vol 134 - N° 10
P. 1247-1251 - octobre 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.